These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20072992)

  • 1. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
    Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
    Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
    Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.
    Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K
    Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
    Raskopf E; Dzienisowicz C; Hilbert T; Rabe C; Leifeld L; Wernert N; Sauerbruch T; Prieto J; Qian C; Caselmann WH; Schmitz V
    Hepatology; 2005 Jun; 41(6):1233-40. PubMed ID: 15915456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.
    Mei J; Gao Y; Zhang L; Cai X; Qian Z; Huang H; Huang W
    Exp Oncol; 2008 Mar; 30(1):29-34. PubMed ID: 18438338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.
    Chen G; Wang Y; Zhou M; Shi H; Yu Z; Zhu Y; Yu F
    Oncol Rep; 2010 Feb; 23(2):563-70. PubMed ID: 20043122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
    Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
    Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of integrin-linked kinase with a small interfering RNA inhibits endothelial cell migration, proliferation and tube formation in vitro.
    Guo L; Yu W; Li X; Zhao G; He P
    Ophthalmic Res; 2009; 42(4):213-20. PubMed ID: 19672130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.